nodes	percent_of_prediction	percent_of_DWPC	metapath
Amiloride—SLC9A1—Barrett's esophagus	0.796	1	CbGaD
Amiloride—Hepatic encephalopathy—Esomeprazole—Barrett's esophagus	0.00945	0.0826	CcSEcCtD
Amiloride—Hepatic encephalopathy—Omeprazole—Barrett's esophagus	0.00945	0.0826	CcSEcCtD
Amiloride—SLC9A1—exocrine gland—Barrett's esophagus	0.00935	0.185	CbGeAlD
Amiloride—SCNN1D—epithelium—Barrett's esophagus	0.00433	0.0856	CbGeAlD
Amiloride—SLC9A1—epithelium—Barrett's esophagus	0.00407	0.0805	CbGeAlD
Amiloride—SLC9A1—smooth muscle tissue—Barrett's esophagus	0.00392	0.0776	CbGeAlD
Amiloride—PLAU—epithelium—Barrett's esophagus	0.00386	0.0763	CbGeAlD
Amiloride—PLAU—smooth muscle tissue—Barrett's esophagus	0.00372	0.0736	CbGeAlD
Amiloride—SCNN1B—epithelium—Barrett's esophagus	0.00366	0.0724	CbGeAlD
Amiloride—SCNN1A—epithelium—Barrett's esophagus	0.00338	0.0669	CbGeAlD
Amiloride—AOC1—digestive system—Barrett's esophagus	0.00323	0.064	CbGeAlD
Amiloride—SLC9A1—digestive system—Barrett's esophagus	0.0031	0.0613	CbGeAlD
Amiloride—PLAU—digestive system—Barrett's esophagus	0.00293	0.0581	CbGeAlD
Amiloride—PLAU—AP-1 transcription factor network—CRTC1—Barrett's esophagus	0.00263	0.067	CbGpPWpGaD
Amiloride—SCNN1A—digestive system—Barrett's esophagus	0.00257	0.0509	CbGeAlD
Amiloride—ASIC2—Ion channel transport—ATP4A—Barrett's esophagus	0.00243	0.0619	CbGpPWpGaD
Amiloride—Foetor hepaticus—Esomeprazole—Barrett's esophagus	0.00242	0.0211	CcSEcCtD
Amiloride—Foetor hepaticus—Omeprazole—Barrett's esophagus	0.00242	0.0211	CcSEcCtD
Amiloride—Encephalopathy—Esomeprazole—Barrett's esophagus	0.00214	0.0187	CcSEcCtD
Amiloride—Encephalopathy—Omeprazole—Barrett's esophagus	0.00214	0.0187	CcSEcCtD
Amiloride—Liver disorder—Esomeprazole—Barrett's esophagus	0.00201	0.0176	CcSEcCtD
Amiloride—Liver disorder—Omeprazole—Barrett's esophagus	0.00201	0.0176	CcSEcCtD
Amiloride—PLAU—E2F transcription factor network—MCL1—Barrett's esophagus	0.00192	0.0491	CbGpPWpGaD
Amiloride—PLAU—Osteopontin Signaling—RELA—Barrett's esophagus	0.00186	0.0475	CbGpPWpGaD
Amiloride—SCNN1G—Ion channel transport—ATP4A—Barrett's esophagus	0.00184	0.0469	CbGpPWpGaD
Amiloride—SCNN1B—Ion channel transport—ATP4A—Barrett's esophagus	0.00184	0.0469	CbGpPWpGaD
Amiloride—SCNN1D—Ion channel transport—ATP4A—Barrett's esophagus	0.00184	0.0469	CbGpPWpGaD
Amiloride—ASIC1—Ion channel transport—ATP4A—Barrett's esophagus	0.00184	0.0469	CbGpPWpGaD
Amiloride—SCNN1A—Ion channel transport—ATP4A—Barrett's esophagus	0.00184	0.0469	CbGpPWpGaD
Amiloride—Hyperuricaemia—Esomeprazole—Barrett's esophagus	0.00148	0.0129	CcSEcCtD
Amiloride—Hyperuricaemia—Omeprazole—Barrett's esophagus	0.00148	0.0129	CcSEcCtD
Amiloride—Blood uric acid increased—Omeprazole—Barrett's esophagus	0.0014	0.0122	CcSEcCtD
Amiloride—Blood uric acid increased—Esomeprazole—Barrett's esophagus	0.0014	0.0122	CcSEcCtD
Amiloride—SLC22A2—digestive system—Barrett's esophagus	0.00139	0.0275	CbGeAlD
Amiloride—Hepatocellular injury—Omeprazole—Barrett's esophagus	0.00137	0.012	CcSEcCtD
Amiloride—Hepatocellular injury—Esomeprazole—Barrett's esophagus	0.00137	0.012	CcSEcCtD
Amiloride—PLAU—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—HGF—Barrett's esophagus	0.00126	0.0321	CbGpPWpGaD
Amiloride—Urine output increased—Esomeprazole—Barrett's esophagus	0.00124	0.0108	CcSEcCtD
Amiloride—Urine output increased—Omeprazole—Barrett's esophagus	0.00124	0.0108	CcSEcCtD
Amiloride—Gynaecomastia—Omeprazole—Barrett's esophagus	0.00123	0.0107	CcSEcCtD
Amiloride—Gynaecomastia—Esomeprazole—Barrett's esophagus	0.00123	0.0107	CcSEcCtD
Amiloride—Hepatic function abnormal—Omeprazole—Barrett's esophagus	0.00114	0.00995	CcSEcCtD
Amiloride—Hepatic function abnormal—Esomeprazole—Barrett's esophagus	0.00114	0.00995	CcSEcCtD
Amiloride—Polyuria—Omeprazole—Barrett's esophagus	0.00113	0.0099	CcSEcCtD
Amiloride—Polyuria—Esomeprazole—Barrett's esophagus	0.00113	0.0099	CcSEcCtD
Amiloride—Visual disturbance—Esomeprazole—Barrett's esophagus	0.00105	0.00918	CcSEcCtD
Amiloride—Visual disturbance—Omeprazole—Barrett's esophagus	0.00105	0.00918	CcSEcCtD
Amiloride—Thirst—Esomeprazole—Barrett's esophagus	0.00105	0.00914	CcSEcCtD
Amiloride—Thirst—Omeprazole—Barrett's esophagus	0.00105	0.00914	CcSEcCtD
Amiloride—SLC22A4—digestive system—Barrett's esophagus	0.00103	0.0204	CbGeAlD
Amiloride—PLAU—FGF signaling pathway—HGF—Barrett's esophagus	0.00103	0.0262	CbGpPWpGaD
Amiloride—Hyponatraemia—Esomeprazole—Barrett's esophagus	0.000999	0.00873	CcSEcCtD
Amiloride—Hyponatraemia—Omeprazole—Barrett's esophagus	0.000999	0.00873	CcSEcCtD
Amiloride—Gastrointestinal haemorrhage—Omeprazole—Barrett's esophagus	0.000995	0.0087	CcSEcCtD
Amiloride—Gastrointestinal haemorrhage—Esomeprazole—Barrett's esophagus	0.000995	0.0087	CcSEcCtD
Amiloride—Pain in extremity—Omeprazole—Barrett's esophagus	0.000995	0.0087	CcSEcCtD
Amiloride—Pain in extremity—Esomeprazole—Barrett's esophagus	0.000995	0.0087	CcSEcCtD
Amiloride—PLAU—Osteopontin-mediated events—RELA—Barrett's esophagus	0.000931	0.0237	CbGpPWpGaD
Amiloride—SLC9A1—Signaling mediated by p38-alpha and p38-beta—PTGS2—Barrett's esophagus	0.00091	0.0232	CbGpPWpGaD
Amiloride—Cramp muscle—Omeprazole—Barrett's esophagus	0.000896	0.00783	CcSEcCtD
Amiloride—Cramp muscle—Esomeprazole—Barrett's esophagus	0.000896	0.00783	CcSEcCtD
Amiloride—Muscular weakness—Omeprazole—Barrett's esophagus	0.000878	0.00767	CcSEcCtD
Amiloride—Muscular weakness—Esomeprazole—Barrett's esophagus	0.000878	0.00767	CcSEcCtD
Amiloride—Abdominal distension—Esomeprazole—Barrett's esophagus	0.000866	0.00757	CcSEcCtD
Amiloride—Abdominal distension—Omeprazole—Barrett's esophagus	0.000866	0.00757	CcSEcCtD
Amiloride—ASIC2—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	0.000845	0.0215	CbGpPWpGaD
Amiloride—PLAU—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CDKN2A—Barrett's esophagus	0.000839	0.0214	CbGpPWpGaD
Amiloride—Angina pectoris—Esomeprazole—Barrett's esophagus	0.000838	0.00732	CcSEcCtD
Amiloride—Angina pectoris—Omeprazole—Barrett's esophagus	0.000838	0.00732	CcSEcCtD
Amiloride—Neutropenia—Esomeprazole—Barrett's esophagus	0.000804	0.00703	CcSEcCtD
Amiloride—Neutropenia—Omeprazole—Barrett's esophagus	0.000804	0.00703	CcSEcCtD
Amiloride—Dysuria—Esomeprazole—Barrett's esophagus	0.000804	0.00703	CcSEcCtD
Amiloride—Dysuria—Omeprazole—Barrett's esophagus	0.000804	0.00703	CcSEcCtD
Amiloride—Pollakiuria—Esomeprazole—Barrett's esophagus	0.000795	0.00694	CcSEcCtD
Amiloride—Pollakiuria—Omeprazole—Barrett's esophagus	0.000795	0.00694	CcSEcCtD
Amiloride—Erectile dysfunction—Esomeprazole—Barrett's esophagus	0.000792	0.00692	CcSEcCtD
Amiloride—Erectile dysfunction—Omeprazole—Barrett's esophagus	0.000792	0.00692	CcSEcCtD
Amiloride—Depression—Esomeprazole—Barrett's esophagus	0.000765	0.00668	CcSEcCtD
Amiloride—Depression—Omeprazole—Barrett's esophagus	0.000765	0.00668	CcSEcCtD
Amiloride—PLAU—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CXCL8—Barrett's esophagus	0.000761	0.0194	CbGpPWpGaD
Amiloride—Jaundice—Omeprazole—Barrett's esophagus	0.000748	0.00653	CcSEcCtD
Amiloride—Jaundice—Esomeprazole—Barrett's esophagus	0.000748	0.00653	CcSEcCtD
Amiloride—Bradycardia—Omeprazole—Barrett's esophagus	0.000701	0.00612	CcSEcCtD
Amiloride—Bradycardia—Esomeprazole—Barrett's esophagus	0.000701	0.00612	CcSEcCtD
Amiloride—Visual impairment—Omeprazole—Barrett's esophagus	0.000664	0.0058	CcSEcCtD
Amiloride—Visual impairment—Esomeprazole—Barrett's esophagus	0.000664	0.0058	CcSEcCtD
Amiloride—PLAU—Wnt Signaling Pathway—APC—Barrett's esophagus	0.000643	0.0164	CbGpPWpGaD
Amiloride—Tinnitus—Esomeprazole—Barrett's esophagus	0.000642	0.00561	CcSEcCtD
Amiloride—Tinnitus—Omeprazole—Barrett's esophagus	0.000642	0.00561	CcSEcCtD
Amiloride—SCNN1G—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	0.00064	0.0163	CbGpPWpGaD
Amiloride—SCNN1A—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	0.00064	0.0163	CbGpPWpGaD
Amiloride—ASIC1—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	0.00064	0.0163	CbGpPWpGaD
Amiloride—SCNN1D—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	0.00064	0.0163	CbGpPWpGaD
Amiloride—SCNN1B—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	0.00064	0.0163	CbGpPWpGaD
Amiloride—Alopecia—Esomeprazole—Barrett's esophagus	0.000608	0.00532	CcSEcCtD
Amiloride—Alopecia—Omeprazole—Barrett's esophagus	0.000608	0.00532	CcSEcCtD
Amiloride—Flatulence—Esomeprazole—Barrett's esophagus	0.000591	0.00516	CcSEcCtD
Amiloride—Flatulence—Omeprazole—Barrett's esophagus	0.000591	0.00516	CcSEcCtD
Amiloride—Tension—Esomeprazole—Barrett's esophagus	0.000588	0.00514	CcSEcCtD
Amiloride—Tension—Omeprazole—Barrett's esophagus	0.000588	0.00514	CcSEcCtD
Amiloride—Nervousness—Omeprazole—Barrett's esophagus	0.000582	0.00509	CcSEcCtD
Amiloride—Nervousness—Esomeprazole—Barrett's esophagus	0.000582	0.00509	CcSEcCtD
Amiloride—Back pain—Omeprazole—Barrett's esophagus	0.00058	0.00507	CcSEcCtD
Amiloride—Back pain—Esomeprazole—Barrett's esophagus	0.00058	0.00507	CcSEcCtD
Amiloride—Muscle spasms—Omeprazole—Barrett's esophagus	0.000576	0.00504	CcSEcCtD
Amiloride—Muscle spasms—Esomeprazole—Barrett's esophagus	0.000576	0.00504	CcSEcCtD
Amiloride—Tremor—Esomeprazole—Barrett's esophagus	0.000562	0.00491	CcSEcCtD
Amiloride—Tremor—Omeprazole—Barrett's esophagus	0.000562	0.00491	CcSEcCtD
Amiloride—SLC9A1—Signaling mediated by p38-alpha and p38-beta—TP53—Barrett's esophagus	0.000541	0.0138	CbGpPWpGaD
Amiloride—Vertigo—Esomeprazole—Barrett's esophagus	0.000538	0.00471	CcSEcCtD
Amiloride—Vertigo—Omeprazole—Barrett's esophagus	0.000538	0.00471	CcSEcCtD
Amiloride—Palpitations—Omeprazole—Barrett's esophagus	0.00053	0.00463	CcSEcCtD
Amiloride—Palpitations—Esomeprazole—Barrett's esophagus	0.00053	0.00463	CcSEcCtD
Amiloride—PLAU—ATF-2 transcription factor network—CXCL8—Barrett's esophagus	0.000524	0.0134	CbGpPWpGaD
Amiloride—Cough—Esomeprazole—Barrett's esophagus	0.000523	0.00457	CcSEcCtD
Amiloride—Cough—Omeprazole—Barrett's esophagus	0.000523	0.00457	CcSEcCtD
Amiloride—ASIC2—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	0.000518	0.0132	CbGpPWpGaD
Amiloride—Chest pain—Esomeprazole—Barrett's esophagus	0.00051	0.00446	CcSEcCtD
Amiloride—Arthralgia—Omeprazole—Barrett's esophagus	0.00051	0.00446	CcSEcCtD
Amiloride—Chest pain—Omeprazole—Barrett's esophagus	0.00051	0.00446	CcSEcCtD
Amiloride—Arthralgia—Esomeprazole—Barrett's esophagus	0.00051	0.00446	CcSEcCtD
Amiloride—PLAU—AP-1 transcription factor network—CDKN2A—Barrett's esophagus	0.000504	0.0128	CbGpPWpGaD
Amiloride—Confusional state—Omeprazole—Barrett's esophagus	0.000493	0.00431	CcSEcCtD
Amiloride—Confusional state—Esomeprazole—Barrett's esophagus	0.000493	0.00431	CcSEcCtD
Amiloride—PLAU—E2F transcription factor network—CDKN2A—Barrett's esophagus	0.000487	0.0124	CbGpPWpGaD
Amiloride—Shock—Omeprazole—Barrett's esophagus	0.000481	0.00421	CcSEcCtD
Amiloride—Shock—Esomeprazole—Barrett's esophagus	0.000481	0.00421	CcSEcCtD
Amiloride—Anorexia—Esomeprazole—Barrett's esophagus	0.000466	0.00407	CcSEcCtD
Amiloride—Anorexia—Omeprazole—Barrett's esophagus	0.000466	0.00407	CcSEcCtD
Amiloride—PLAU—Wnt Signaling Pathway and Pluripotency—APC—Barrett's esophagus	0.000459	0.0117	CbGpPWpGaD
Amiloride—PLAU—AP-1 transcription factor network—CXCL8—Barrett's esophagus	0.000457	0.0117	CbGpPWpGaD
Amiloride—Musculoskeletal discomfort—Omeprazole—Barrett's esophagus	0.000446	0.00389	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Esomeprazole—Barrett's esophagus	0.000446	0.00389	CcSEcCtD
Amiloride—Insomnia—Esomeprazole—Barrett's esophagus	0.000442	0.00387	CcSEcCtD
Amiloride—Insomnia—Omeprazole—Barrett's esophagus	0.000442	0.00387	CcSEcCtD
Amiloride—Paraesthesia—Esomeprazole—Barrett's esophagus	0.000439	0.00384	CcSEcCtD
Amiloride—Paraesthesia—Omeprazole—Barrett's esophagus	0.000439	0.00384	CcSEcCtD
Amiloride—Dyspnoea—Omeprazole—Barrett's esophagus	0.000436	0.00381	CcSEcCtD
Amiloride—Dyspnoea—Esomeprazole—Barrett's esophagus	0.000436	0.00381	CcSEcCtD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—APC—Barrett's esophagus	0.000436	0.0111	CbGpPWpGaD
Amiloride—Somnolence—Omeprazole—Barrett's esophagus	0.000435	0.0038	CcSEcCtD
Amiloride—Somnolence—Esomeprazole—Barrett's esophagus	0.000435	0.0038	CcSEcCtD
Amiloride—Dyspepsia—Esomeprazole—Barrett's esophagus	0.000431	0.00376	CcSEcCtD
Amiloride—Dyspepsia—Omeprazole—Barrett's esophagus	0.000431	0.00376	CcSEcCtD
Amiloride—Decreased appetite—Esomeprazole—Barrett's esophagus	0.000425	0.00372	CcSEcCtD
Amiloride—Decreased appetite—Omeprazole—Barrett's esophagus	0.000425	0.00372	CcSEcCtD
Amiloride—Gastrointestinal disorder—Omeprazole—Barrett's esophagus	0.000422	0.00369	CcSEcCtD
Amiloride—Gastrointestinal disorder—Esomeprazole—Barrett's esophagus	0.000422	0.00369	CcSEcCtD
Amiloride—SLC9A1—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	0.000422	0.0108	CbGpPWpGaD
Amiloride—Fatigue—Omeprazole—Barrett's esophagus	0.000422	0.00369	CcSEcCtD
Amiloride—Fatigue—Esomeprazole—Barrett's esophagus	0.000422	0.00369	CcSEcCtD
Amiloride—Constipation—Omeprazole—Barrett's esophagus	0.000418	0.00366	CcSEcCtD
Amiloride—Constipation—Esomeprazole—Barrett's esophagus	0.000418	0.00366	CcSEcCtD
Amiloride—Pain—Omeprazole—Barrett's esophagus	0.000418	0.00366	CcSEcCtD
Amiloride—Pain—Esomeprazole—Barrett's esophagus	0.000418	0.00366	CcSEcCtD
Amiloride—Feeling abnormal—Esomeprazole—Barrett's esophagus	0.000403	0.00352	CcSEcCtD
Amiloride—Feeling abnormal—Omeprazole—Barrett's esophagus	0.000403	0.00352	CcSEcCtD
Amiloride—Gastrointestinal pain—Omeprazole—Barrett's esophagus	0.0004	0.0035	CcSEcCtD
Amiloride—Gastrointestinal pain—Esomeprazole—Barrett's esophagus	0.0004	0.0035	CcSEcCtD
Amiloride—SCNN1A—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	0.000393	0.01	CbGpPWpGaD
Amiloride—SCNN1D—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	0.000393	0.01	CbGpPWpGaD
Amiloride—ASIC1—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	0.000393	0.01	CbGpPWpGaD
Amiloride—SCNN1B—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	0.000393	0.01	CbGpPWpGaD
Amiloride—SCNN1G—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	0.000393	0.01	CbGpPWpGaD
Amiloride—Abdominal pain—Omeprazole—Barrett's esophagus	0.000387	0.00338	CcSEcCtD
Amiloride—Abdominal pain—Esomeprazole—Barrett's esophagus	0.000387	0.00338	CcSEcCtD
Amiloride—SLC9A1—Regulation of Actin Cytoskeleton—APC—Barrett's esophagus	0.000376	0.00959	CbGpPWpGaD
Amiloride—PLAU—Senescence and Autophagy in Cancer—CDKN2A—Barrett's esophagus	0.000364	0.00929	CbGpPWpGaD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—CDKN2A—Barrett's esophagus	0.000354	0.00902	CbGpPWpGaD
Amiloride—Asthenia—Omeprazole—Barrett's esophagus	0.000351	0.00307	CcSEcCtD
Amiloride—Asthenia—Esomeprazole—Barrett's esophagus	0.000351	0.00307	CcSEcCtD
Amiloride—Pruritus—Esomeprazole—Barrett's esophagus	0.000346	0.00302	CcSEcCtD
Amiloride—Pruritus—Omeprazole—Barrett's esophagus	0.000346	0.00302	CcSEcCtD
Amiloride—Diarrhoea—Esomeprazole—Barrett's esophagus	0.000335	0.00292	CcSEcCtD
Amiloride—Diarrhoea—Omeprazole—Barrett's esophagus	0.000335	0.00292	CcSEcCtD
Amiloride—PLAU—Senescence and Autophagy in Cancer—CXCL8—Barrett's esophagus	0.00033	0.00842	CbGpPWpGaD
Amiloride—Dizziness—Omeprazole—Barrett's esophagus	0.000323	0.00283	CcSEcCtD
Amiloride—Dizziness—Esomeprazole—Barrett's esophagus	0.000323	0.00283	CcSEcCtD
Amiloride—Vomiting—Omeprazole—Barrett's esophagus	0.000311	0.00272	CcSEcCtD
Amiloride—Vomiting—Esomeprazole—Barrett's esophagus	0.000311	0.00272	CcSEcCtD
Amiloride—Rash—Esomeprazole—Barrett's esophagus	0.000308	0.00269	CcSEcCtD
Amiloride—Rash—Omeprazole—Barrett's esophagus	0.000308	0.00269	CcSEcCtD
Amiloride—Dermatitis—Omeprazole—Barrett's esophagus	0.000308	0.00269	CcSEcCtD
Amiloride—Dermatitis—Esomeprazole—Barrett's esophagus	0.000308	0.00269	CcSEcCtD
Amiloride—Headache—Esomeprazole—Barrett's esophagus	0.000306	0.00268	CcSEcCtD
Amiloride—Headache—Omeprazole—Barrett's esophagus	0.000306	0.00268	CcSEcCtD
Amiloride—Nausea—Esomeprazole—Barrett's esophagus	0.000291	0.00254	CcSEcCtD
Amiloride—Nausea—Omeprazole—Barrett's esophagus	0.000291	0.00254	CcSEcCtD
Amiloride—PLAU—AP-1 transcription factor network—TP53—Barrett's esophagus	0.00028	0.00715	CbGpPWpGaD
Amiloride—SLC22A4—SLC-mediated transmembrane transport—SLC9A1—Barrett's esophagus	0.000233	0.00594	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PTGES—Barrett's esophagus	0.000222	0.00566	CbGpPWpGaD
Amiloride—PLAU—Wnt Signaling Pathway and Pluripotency—TP53—Barrett's esophagus	0.000208	0.00529	CbGpPWpGaD
Amiloride—PLAU—Senescence and Autophagy in Cancer—TP53—Barrett's esophagus	0.000203	0.00517	CbGpPWpGaD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—TP53—Barrett's esophagus	0.000197	0.00502	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	0.000193	0.00493	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—HGF—Barrett's esophagus	0.000172	0.00438	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—CYP26A1—Barrett's esophagus	0.000168	0.00429	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	0.000118	0.00302	CbGpPWpGaD
Amiloride—SLC22A2—SLC-mediated transmembrane transport—SLC9A1—Barrett's esophagus	0.00011	0.00281	CbGpPWpGaD
Amiloride—SLC22A1—SLC-mediated transmembrane transport—SLC9A1—Barrett's esophagus	0.000103	0.00262	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	9.14e-05	0.00233	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	8.52e-05	0.00217	CbGpPWpGaD
Amiloride—SLC9A1—Disease—APC—Barrett's esophagus	6.85e-05	0.00175	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—TP53—Barrett's esophagus	5.76e-05	0.00147	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	5.6e-05	0.00143	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PPARG—Barrett's esophagus	5.53e-05	0.00141	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	5.22e-05	0.00133	CbGpPWpGaD
Amiloride—SLC9A1—Disease—PTGS2—Barrett's esophagus	5.2e-05	0.00132	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PTGES—Barrett's esophagus	4.8e-05	0.00122	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PTGES—Barrett's esophagus	4.48e-05	0.00114	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PTGS2—Barrett's esophagus	4.35e-05	0.00111	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CYP26A1—Barrett's esophagus	3.64e-05	0.000928	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CYP26A1—Barrett's esophagus	3.39e-05	0.000865	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—SLC9A1—Barrett's esophagus	2.62e-05	0.000669	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—SLC9A1—Barrett's esophagus	2.45e-05	0.000623	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PPARG—Barrett's esophagus	1.2e-05	0.000305	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PPARG—Barrett's esophagus	1.12e-05	0.000285	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PTGS2—Barrett's esophagus	9.42e-06	0.00024	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PTGS2—Barrett's esophagus	8.78e-06	0.000224	CbGpPWpGaD
